New Delhi, May 27 -- Mankind Pharma is focused on expanding its presence in the gastrointestinal and dermatology segments this year, as it looks at expanding its presence in the chronic segments, managing director Rajeev Juneja toldMintin an interview.

"We are not great in the gastro [segment]...we have decided that we are supposed to work a lot in gastro because it has become semi-chronic, and our inclination is towards the chronic side," Juneja said, adding thatgastro in India is one of the fastest-growing segments.

"Along with this, we are working on derma as well," he said.

The gastro segment grew 7.3% year on year in April, according to pharma intelligence platform Pharmarack.

Further, Mankind is developing a novel anti-obesity a...